A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(26 sites)

United States

Clinical Study Site, Scottsdale, Arizona

Clinical Study Site, Los Angeles, California

Clinical Study Site, Bradenton, Florida

Clinical Study Site, Tampa, Florida

Clinical Study Site, Honolulu, Hawaii